Found 45 matching trials
Open-Label Study of H5 Vaccine in Participants of Protocol 04-077
PHASE1This study may provide safety information on a flu vaccine given to childre...
Location
UCLA Center For Vaccine Research
Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly
PHASE2This is a randomized, double-blinded, Phase II study in healthy males and n...
Location
The Hope Clinic of Emory University
Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels
PHASE2The purpose of this study is to assess the safety and the body's immune res...
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age
PHASE3This study will evaluate the safety and immunogenicity in healthy children ...
Location
Centro de Atención e Investigación Medica - CAIMED
Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)
PHASE3The clinical trial was conducted in Jintan City of Jiangsu Province, China ...
Location
Jiangsu Provincial Center for Disease Prevention and Control
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot
EARLY_PHASE1A new flu vaccine which is injected into the skin instead of into the muscl...
Location
National Jewish Health
Influenza Vaccination in the Emergency Department
NARandomized controlled trial of influenza vaccination versus referral for va...
Location
University of Arizona
Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)
PHASE2The study is a single centre, phase II, double-blind, randomized, comparati...
Location
Kazakh National Medical University
Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1
PHASE1The purpose of this study is to compare the safety and immunogenicity over ...
Location
University of Kentucky
H5 Booster After a Two Dose Schedule
PHASE2The purpose of this study is to determine whether a third dose of vaccines ...
Location
UCLA Center For Vaccine Research